News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
Renowned Cancer Theorist Dies
Alison F. Takemura | Jul 12, 2016
Alfred Knudson, who formulated the “two-hit” theory on the origins of cancer, has passed away at age 93.
New FDA Center Aims to Expedite Cancer Treatment Reviews
Alison F. Takemura | Jun 30, 2016
The Oncology Center of Excellence, a product of the White House’s Cancer Moonshot initiative, will bring together oncologists across the US Food and Drug Administration.
Thirumala-Devi Kanneganti: Immersed in Immunology
Karen Zusi | Jun 1, 2016
Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43
AACR Q&A: Angelika Amon
Staff | Apr 19, 2016
The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.
Antioxidants Again Linked to Cancer’s Spread
Anna Azvolinsky | Apr 13, 2016
Certain diabetes drugs with antioxidant properties promote metastasis in mice with existing tumors, researchers report.
Kerry Grens | Apr 1, 2016
After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.
Catherine Offord | Apr 1, 2016
Exosomes are emerging as key players in metastasis.
Ruth Williams | Apr 1, 2016
A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.